Biogen HQ Gets New Investor in $476M Deal
A recapitalization of Biogen’s U.S. headquarters values the Kendall Square property at $476 million, an increase of 75 percent from its last change of ownership in 2015.
by Steve Adams | Jan 3, 2022
A recapitalization of Biogen’s U.S. headquarters values the Kendall Square property at $476 million, an increase of 75 percent from its last change of ownership in 2015.
We're sorry, it appears you don't have the proper subscription to view this page. Please click the button below to purchase or renew your subscription and gain access to this content.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
It appears someone has logged in to your account from another device. Please click the button below to log back in on this device, and terminate all other sessions.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
Already have a subscription?
Need a subscription?
Special offer for new subscribers –
try B&T online for just $9.99 for your first month!
Just looking for the headlines?
If you need assistance with your subscription, please visit our customer service form or email customerservice@thewarrengroup.com.